...This chapter discusses the patenting of the CCR5 gene in Europe. It compares and contrasts the practices of the United States Patent and Trademark Office (USPTO) with the European Patent Office (EPO) with regard to gene patenting. It also focuses on the anatomy of opposing...

... illustrates how lenient the United States Patent and Trademark Office (USPTO) was in granting gene patents back in the 1990s with a view to encourage growth in the biotechnology sector. It also discusses the views of numerous biomedical researchers on the patenting of the gene by sequencing companies. Alberts...

... utility claims National Institutes of Health United States Patent and Trademark Office Biotechnology Industry Organization (BIO) The previous chapter analyzes the patentability of natural products, which is relevant to all gene patents. The lack of legal clarity described in that chapter is also...